FIGURE

Fig. 7

ID
ZDB-FIG-250909-38
Publication
Guzman et al., 2025 - B-rich colistin and B-pure colistin as novel strategies to increase the therapeutic window of polymyxin antibiotic therapy
Other Figures
All Figure Page
Back to All Figure Page
Fig. 7

Lethal and neurotoxic effects of colistin A and B. Comparison of A) lethality curves and B) TER assay obtained from zebrafish embryos exposed from 6 to 72 hpf to A-pure or B-pure colistin. C) Results of the accumulated lethality and D) TER assay from embryos exposed to the minority compounds of B-rich colistin formulation. Results are expressed as the mean ± SEM of a minimum of 3 independent experiments with 10 embryos per group in lethality assays (total of 30 embryos/group) or 6 for the touch-evoked response assay (total of 18 embryos/group). To compare the differences between colistin subtypes (A and B), two-way ANOVA with Sidak’s post-hoc test was used. One-way ANOVA with Bonferroni’s pos-hoc test was used to statistically identify differences between concentrations in lethality and TER assay (C and D). LC50 = Lethal concentration 50, CI 95 % LC50= 95 % confidence interval of the LC50, NOAEC= No Observed Adverse Effect Concentration. * Indicates differences with the control. # indicates differences between colistin types. In all cases a p < 0.05 was used to consider statistical differences.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.